AIM 01Investigate how mutations in PUM1 affect neurological function.
AIM 02Determine the distinct pathogenic pathways for PRCA and PADDAS.
AIM 03Characterize molecular profiles in patient-derived cell lines.
AIM 04Explore the interactions of PUM1 with other proteins in the brain.